Ascopiave SpA
F:AVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ascopiave SpA
F:AVA
|
IT |
|
ImmunoCellular Therapeutics Ltd
OTC:IMUC
|
US |
|
FARO Technologies Inc
NASDAQ:FARO
|
US |
Wall St Price Targets
AVA Price Targets Summary
Ascopiave SpA
According to Wall Street analysts, the average 1-year price target for
AVA is 4.52 EUR with a low forecast of 4.36 EUR and a high forecast of 4.78 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AVA's stock price target?
Price Target
4.52
EUR
According to Wall Street analysts, the average 1-year price target for
AVA is 4.52 EUR with a low forecast of 4.36 EUR and a high forecast of 4.78 EUR.
What is the Revenue forecast for Ascopiave SpA?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been -11%. The projected CAGR for the next 4 years is 8%.
What is the Gross Profit forecast for Ascopiave SpA?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 3 years is -3%.
What is the Operating Income forecast for Ascopiave SpA?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 4 years is 1%.
What is the Pre-Tax Income forecast for Ascopiave SpA?
Projected CAGR
-14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is -14%.
What is the Net Income forecast for Ascopiave SpA?
Projected CAGR
-16%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 4 years is -16%.